- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pediatric Multiple Sclerosis in Australia
Total 578 results
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgenCompletedMultiple MyelomaAustria, Germany
-
Novartis PharmaceuticalsCompletedTreatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome PatientsAustria, Switzerland
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
ActelionTerminatedSystemic Sclerosis | Pulmonary Arterial Hypertension | Pulmonary HypertensionUnited States, Canada, Spain, Hungary, Switzerland, Turkey, Germany, Austria, Bosnia and Herzegovina, Brazil, China, Czech Republic, Netherlands, Norway, Poland, Puerto Rico, Romania, Russian Federation, Slovakia, United Kingdom
-
NovartisCompletedMultiple MyelomaCanada, United States, Australia, Taiwan, Ireland
-
Mirum Pharmaceuticals, Inc.CompletedAlagille SyndromeFrance, Belgium, Poland, Australia, Spain, United Kingdom
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellUnited States, Australia
-
Bristol-Myers SquibbChildren's Oncology Group; EsPhALLCompletedLeukemia, PediatricUnited States, Canada, United Kingdom, Italy, Australia, Puerto Rico
-
Ascendis Pharma Endocrinology Division A/SCompletedA Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone DeficiencyEndocrine System Diseases | Pituitary Diseases | Hormone Deficiency | Growth Hormone Deficiency, PediatricUnited States, Canada, Australia, New Zealand
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
Pharmacyclics LLC.Celgene CorporationTerminatedMultiple MyelomaUnited States, Spain, Australia, Czechia, Germany, Greece
-
SanofiCompletedPlasma Cell MyelomaFrance, Italy, Czechia, Greece, Spain, Canada, Australia, United States, Brazil, Hungary
-
SanofiCompletedMultiple MyelomaFrance, Spain, Belgium, Australia, United States, Japan
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Taiwan, Spain, Australia, Brazil, France, United Kingdom, Poland, Singapore, Italy
-
Ovid Therapeutics Inc.CompletedPrimary Disease or Condition Being Studied: Angelman Syndrome (AS)United States, Australia, Germany, Israel, Netherlands
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Austria, Denmark, Canada, Australia, China, Spain, Germany, United Kingdom, Hungary, Taiwan, Israel, Japan, India, Norway, Brazil, Italy, Greece, Korea, Republic of, Colombia, Singapore, Netherlands, Argentina, Hong Kong, Romani... and more
-
BioCryst PharmaceuticalsActive, not recruitingHereditary Angioedema | PediatricSpain, Austria, Canada, France, Germany, Israel, Italy, Poland, Romania, United Kingdom
-
Janssen Research & Development, LLCActive, not recruitingA Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple MyelomaMultiple MyelomaUnited States, Australia, France, United Kingdom, Germany, Israel, Turkey, Netherlands, Canada, Russian Federation, Czechia
-
AbbVieTerminatedMultiple MyelomaUnited States, Australia, France, Germany, Israel, Japan, Spain
-
Genentech, Inc.RecruitingMultiple MyelomaUnited States, Canada, Spain, Australia
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Italy, Germany, France, Japan, Israel, Belgium, Denmark, Sweden, Canada, Spain, Czechia, Poland, Australia, Netherlands, United Kingdom, India, China
-
Arbeitsgemeinschaft medikamentoese TumortherapieCompletedMultiple MyelomaCzechia, Austria, Germany
-
Hoffmann-La RocheRecruitingMultiple MyelomaBelgium, Korea, Republic of, Denmark, United Kingdom, Australia, New Zealand, Italy, Spain, France
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
AstraZenecaRecruitingMultiple MyelomaUnited States, Spain, Australia, Canada, Germany, China, Japan
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Denmark, Australia, Belgium, Finland, Greece, Japan, Korea, Republic of, Spain, United Kingdom
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada, Australia, China, Germany, Belgium, Malaysia, Turkey, Japan, Israel, Sweden, Spain, United Kingdom, Czechia, Denmark, Brazil, Italy, France, Netherlands, Poland, Austria, Portugal, Greece, India
-
GlaxoSmithKlineRecruitingMultiple MyelomaChina, Korea, Republic of, Australia, Italy, Spain, United States, Brazil, Czechia, France, Germany, Greece, Israel, Japan, New Zealand, Poland, Russian Federation, Turkey, United Kingdom
-
Alterity TherapeuticsRecruitingMultiple System AtrophyUnited States, Australia, New Zealand, United Kingdom, Italy, France, Austria
-
Ultragenyx Pharmaceutical IncNot yet recruitingAngelman SyndromeUnited States, Australia, Canada, Germany, United Kingdom, Israel, France, Spain
-
OPKO Health, Inc.Active, not recruitingSafety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient ChildrenPediatric Growth Hormone DeficiencyIsrael, United States, India, Korea, Republic of, Australia, Taiwan, Spain, Argentina, Belarus, Bulgaria, Canada, Colombia, Georgia, Greece, Mexico, New Zealand, Poland, Russian Federation, Ukraine, United Kingdom
-
BayerWithdrawnMultiple MyelomaBelgium, Spain, Korea, Republic of, Taiwan, United States, Australia, Germany, Israel, Italy, Greece, Canada
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
CelgeneCompletedMultiple MyelomaSpain, United Kingdom, Switzerland, Australia, Israel, Italy, Poland, France, Belgium, Ireland, Austria, Germany, Ukraine, Greece, Sweden
-
AmgenCompletedMultiple MyelomaFrance, Poland, United Kingdom, Belgium, Germany, Spain, Israel, Serbia, Australia, Greece, Korea, Republic of, Russian Federation, Hungary, Sweden, Austria, Slovakia, Italy, Czechia, New Zealand
-
University of WuerzburgUnknownMultiple MyelomaGermany, Austria
-
Ultragenyx Pharmaceutical IncActive, not recruitingAngelman SyndromeUnited States, United Kingdom, Canada, Australia, France, Germany, Spain, Israel
-
SanofiRecruitingPlasma Cell Myeloma RefractoryFrance, Australia, Greece, Italy, Norway, United States, Portugal, Puerto Rico
-
Ascendis Pharma A/SCompletedEndocrine System Diseases | Pituitary Diseases | Hormone Deficiency | Growth Hormone Deficiency, PediatricUnited States, Armenia, Belarus, Bulgaria, Georgia, Greece, Russian Federation, Ukraine, Australia, New Zealand, Poland
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
AmgenCompletedThrombocytopenia in Pediatric Subjects With Immune Idiopathic Thrombocytopenic Purpura ITPUnited States, Canada, Australia, Spain
-
SanofiTerminatedCongenital Cystic Kidney DiseaseGermany, Spain, United States, Australia, Belgium, Japan, Korea, Republic of, Netherlands
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, United Kingdom, Netherlands, France, Australia
-
Genentech, Inc.Hoffmann-La RocheRecruitingMultiple MyelomaKorea, Republic of, United States, Denmark, Italy, Spain, France, Japan, Israel, United Kingdom, Poland, Australia, Canada, Czechia
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Belgium, United Kingdom, France, Australia
-
Novartis PharmaceuticalsCompletedNevoid Basal Cell Carcinoma Syndrome | Basal Cell Carcinoma | Gorlin SyndromeBelgium, Austria, Germany, Canada
-
German Parkinson Study Group (GPS)Competence Network on Parkinson's Disease; European MSA-Study Group; Federal...CompletedMulti-System-Atrophy | MinocyclineAustria, Germany
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway
-
TakedaActive, not recruitingPediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL) | Ph+ Mixed Phenotype Acute Leukemia (MPAL) | Philadelphia Chromosome-Like ALL (Ph-like ALL)United States, France, Korea, Republic of, China, Spain, United Kingdom, Czechia, Portugal, Brazil, Argentina, Italy, Australia, Mexico, Netherlands, Poland